Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Xilio Therapeutics
828 Winter Street
Waltham, MA 02451
Phone: 617-430-4762

Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The company's tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across cancer types means that all patients could benefit from these potentially curative medicines.

Key Contact
Rene Russo
Funding Events

03/02/20 $100,500,000 Series B Atlas Venture
Bay City Capital
F-Prime Capital Partners
M Ventures
MRL Ventures Fund
RiverVest Venture Partners
Solasta Ventures
SV Health Investors
Takeda Ventures
02/25/21 $95,000,000 Series C Atlas Venture
Bain Capital Life Sciences
Deerfield Management Company, L.P.
MRL Ventures Fund
RA Capital Management
RiverVest Venture Partners
Rock Springs Capital
SV Health Investors
Takeda Ventures

Featured Reading